CN110291060A - 制备取代卟啉药物化合物和组合物的方法 - Google Patents

制备取代卟啉药物化合物和组合物的方法 Download PDF

Info

Publication number
CN110291060A
CN110291060A CN201780086851.4A CN201780086851A CN110291060A CN 110291060 A CN110291060 A CN 110291060A CN 201780086851 A CN201780086851 A CN 201780086851A CN 110291060 A CN110291060 A CN 110291060A
Authority
CN
China
Prior art keywords
weight
compound
formula
composition
anion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780086851.4A
Other languages
English (en)
Chinese (zh)
Inventor
I.巴蒂尼奇-哈伯勒
A.托夫马斯彦
Z.R.措利奇
I.斯帕索杰维奇
C.A.李
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beomi Aesthetic Joint Venture Co Ltd
Duke University
Original Assignee
Beomi Aesthetic Joint Venture Co Ltd
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beomi Aesthetic Joint Venture Co Ltd, Duke University filed Critical Beomi Aesthetic Joint Venture Co Ltd
Publication of CN110291060A publication Critical patent/CN110291060A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B47/00—Formation or introduction of functional groups not provided for in groups C07B39/00 - C07B45/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
CN201780086851.4A 2016-12-20 2017-12-19 制备取代卟啉药物化合物和组合物的方法 Pending CN110291060A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662436743P 2016-12-20 2016-12-20
US62/436743 2016-12-20
PCT/US2017/067263 WO2018118891A1 (en) 2016-12-20 2017-12-19 Methods of making substituted porphyrin pharmaceutical compounds and compositions

Publications (1)

Publication Number Publication Date
CN110291060A true CN110291060A (zh) 2019-09-27

Family

ID=62628012

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780086851.4A Pending CN110291060A (zh) 2016-12-20 2017-12-19 制备取代卟啉药物化合物和组合物的方法

Country Status (8)

Country Link
US (1) US20190330220A1 (enExample)
EP (1) EP3558902A4 (enExample)
JP (1) JP2020502280A (enExample)
KR (1) KR20190098211A (enExample)
CN (1) CN110291060A (enExample)
CA (1) CA3046357A1 (enExample)
MX (1) MX2019007301A (enExample)
WO (1) WO2018118891A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018187411A1 (en) * 2017-04-04 2018-10-11 Biomimetix Jv, Llc Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure
WO2019067523A1 (en) * 2017-09-29 2019-04-04 Duke University FLUOROSUBSTITUTED PORPHYRIN COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF PREPARATION AND USE THEREOF

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1355802A (zh) * 1999-01-25 2002-06-26 国家犹太医疗及研究中心 取代的卟啉
US6583132B1 (en) * 1993-10-15 2003-06-24 Duke University Oxidant scavengers
WO2005077269A1 (en) * 2004-02-09 2005-08-25 Duke University Substituted porphyrins
WO2010138633A1 (en) * 2009-05-26 2010-12-02 Duke University Method of providing neuroprotection using substituted porphyrins
US20160324868A1 (en) * 2014-01-22 2016-11-10 Duke University Methods of treating pruritus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1513537A4 (en) * 2002-06-07 2006-09-06 Univ Duke Substituted porphyrins
US20110275606A1 (en) * 2009-01-07 2011-11-10 Duke University Substituted porphyrins

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6583132B1 (en) * 1993-10-15 2003-06-24 Duke University Oxidant scavengers
CN1355802A (zh) * 1999-01-25 2002-06-26 国家犹太医疗及研究中心 取代的卟啉
US20150231150A1 (en) * 1999-01-25 2015-08-20 Aeolus Sciences, Inc. Substituted porphyrins
WO2005077269A1 (en) * 2004-02-09 2005-08-25 Duke University Substituted porphyrins
US20100305083A1 (en) * 2004-02-09 2010-12-02 Ines Batinic-Haberle Substituted porphyrins
WO2010138633A1 (en) * 2009-05-26 2010-12-02 Duke University Method of providing neuroprotection using substituted porphyrins
US20160324868A1 (en) * 2014-01-22 2016-11-10 Duke University Methods of treating pruritus

Also Published As

Publication number Publication date
KR20190098211A (ko) 2019-08-21
US20190330220A1 (en) 2019-10-31
CA3046357A1 (en) 2018-06-28
EP3558902A1 (en) 2019-10-30
EP3558902A4 (en) 2020-06-24
JP2020502280A (ja) 2020-01-23
WO2018118891A1 (en) 2018-06-28
MX2019007301A (es) 2019-10-30

Similar Documents

Publication Publication Date Title
KR102548191B1 (ko) 표적 단백질 분해 화합물, 이의 항종양 응용, 이의 중간체 및 중간체의 응용
AU2019201325B2 (en) Amyloid targeting agents and methods of using the same
CN111065639B (zh) 一类细胞周期依赖性激酶的降解剂、其制备方法、药物组合物及其用途
TWI630201B (zh) 化合物及其調節血紅素之用途
TWI756257B (zh) 吡啶酮醯胺類衍生物、其製備方法及其在醫藥上的應用
JP6401771B2 (ja) ヘモグロビンの修飾のための化合物及びその使用
EP4382530A1 (en) Shp2 inhibitor, pharmaceutical composition comprising same, and application thereof
CN114845997A (zh) 芳香类化合物及其在制备抗肿瘤药物中的应用
CN114901663A (zh) 一类芳香杂环类化合物及其在药物中的应用
EP2223926B1 (en) Pyridine derivative substituted with heterocycle and phosphonoxymethyl group and antifungal agent containing the same
KR20230019101A (ko) 벤조티아졸릴 비아릴 화합물, 제조 방법 및 용도
EP2781519B1 (en) Novel antiviral pyrrolopyridine derivative and a production method for same
JP2024123011A (ja) セピプテリン及びその塩の多形
TW202436298A (zh) 離子通道調節劑
KR102442536B1 (ko) 리나글립틴 결정형 및 이의 제조방법
US20200165239A1 (en) Protein kinase inhibitors, preparation method and medical use thereof
AU2020382827A1 (en) 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient CFTR activity
WO2014055618A1 (en) Solid state forms of hiv inhibitor: hemi-succinate of (2s)-2-tert-butoxy-2-(4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid)
JPWO2020128925A5 (enExample)
CN110291060A (zh) 制备取代卟啉药物化合物和组合物的方法
WO2013036766A1 (en) Small molecule naphthoquinone- and phthalimide-based lipocations as anti-parasitic agents
WO2015006535A2 (en) Dictyostatin prodrugs and methods of their use
CN115427407A (zh) 一种新型n-杂环bet溴结构域抑制剂、其制备方法及医药用途
KR20230128056A (ko) 삼환식 화합물, 및 그의 제조 방법 및 그의 의학적용도
JP2022553801A (ja) Ｓ１ｐ受容体モジュレーターを調製するためのプロセス

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190927